(Mon) Walmart to soon launch Amazon Prime rival
¿ù¸¶Æ®, ¾Æ¸¶Á¸ ÇÁ¶óÀÓ¿¡ ´ëÇÑ ´ëÇ׸¶ Ãâ½Ã ÀÓ¹Ú
Walmart is reportedly prepared to step up its online fight with Amazon.com by launching a membership program to compete with the online giant's very successful Prime service. Investors are totally buying the idea and sent Walmart's stock more than 6 percent higher on Tuesday. The Walmart subscription service, which will be called Walmart+, according to reporting by tech website Recode, is due to launch later this month at $98 a year. That's about $20 cheaper than the annual fee for Amazon Prime. But how will Walmart+ stack up when it comes to services? Customers will reportedly get same-day delivery options for groceries and other merchandise, discounts at the retailer's gas stations, and early access to deals. No word yet on whether Walmart+ shoppers will get quicker, free shipping. Right now, two-day shipping is free for all customers spending at least $35. Walmart declined to comment on the report. But it has been making an effort to close the wide gap between its online sales and that of Amazon.com. Last quarter it set a company record for online sales with a near 75 percent jump in spending on its website... And it recently announced a partnership with Canadian e-commerce firm Shopify in an attempt to capture a bigger slice of online shopping. It still has a way to go to catch up to Amazon as far as Wall Street is concerned. Amazon shares were down slightly on Tuesday but held above the marquee $3,000 price tag - giving it a $1.5 trillion stock market valuation. Walmart's market cap is just a fraction of that at nearly $360 billion.
(Tue) China warns UK: dropping Huawei will cost you
Áß±¹, ¿µ±¹ÀÇ È¿þÀÌ ¹èÁ¦¿¡ ´ëÇØ °æ°í
China has a warning for the UK: drop Huawei, and there will be trouble. The country¡¯s ambassador to London made the not-so veiled threat on Monday: "So we want to be your friend, we want to be your partner, but if you want to make China a hostile country you have to bear the consequences.¡± Liu Xiaoming spoke amid hints that the UK might, after all, ban Huawei from working on its next-generation 5G phone networks. Earlier London had said the Chinese firm could be involved in non-core parts of the network. But last week saw UK Prime Minister Boris Johnson say he didn¡¯t want critical infrastructure controlled by ¡®potentially hostile state vendors¡¯. That after the U.S. tightened sanctions on Huawei, and ramped up pressure on allies to shun it. It all leaves London with a tough choice: whether to anger Washington, or Beijing. The Chinese ambassador turned it into a test of post-Brexit Britain: "But when you get rid of Huawei it sends out a very wrong message. It punishes the British image as a free business, free trade country.¡± The tussle over Huawei has become a battle of wills between the U.S. and China. On Monday one UK minister said a review of its policy was under way, with results to be announced to parliament. Boris Johnson has a very tough choice to make.
(Wed) Anger as Air France cuts jobs despite bailout
¿¡¾îÇÁ¶û½º, ±¸Á¦±ÝÀ¶ Áö¿ø¿¡µµ ºÒ±¸ °¨¿ø °èȹÇÏ¸ç ºÐ³ë Ã˹ß
Protests Friday outside Air France offices in Paris. That as the airline looks set to shed around 7,500 jobs. The cuts will affect about 15% of the firm¡¯s employees, including pilots, stewards and ground staff. At least half that number is likely to entail voluntary departures and retirement plans. But that still leaves the prospect of thousands of compulsory redundancies. And that has sparked anger, coming just weeks after chief executive Ben Smith secured a state bailout valued at 7 billion euros - or almost 7.9 billion dollars. Long-time staffer Valerie Raphel joined the protests: "Yes, we have a feeling of injustice, we also have a feeling of betrayal and of complicity with the government because the state didn't impose compromises on Benjamin Smith in terms of preserving jobs in exchange for the billions of euros that have been loaned to us.¡± On Friday ministers called on Air France to pursue cutbacks ¡®responsibly¡¯, urging it to avoid forcible departures. The airline says it has no choice but to make changes though. Like rivals, it¡¯s been hard hit by the global slump in air travel. It¡¯s the French half of the broader Air France-KLM group. The Dutch government has given KLM a bailout worth 3.4 billion euros - about 3.8 billion dollars. Friday¡¯s news caps a bad few days for airlines and their suppliers. Plane maker Airbus said this week it would cut 15,000 jobs across Europe. Budget airline easyJet laid off more workers, and rival Ryanair warned that thousands of jobs could be at risk.
(Thu) S.Korea talks COVID-19 drug, U.S. buys most stocks
¹Ì±¹ ·½µ¥½Ãºñ¸£ ¹°·® ¼±Á¡ÇÑ °¡¿îµ¥, Á¦Á¶»ç¿Í Çù»ó °èȹÁßÀÎ Çѱ¹
South Korea has started distributing stocks of the COVID-19 treatment remdesivir that were donated by the drugmaker Gilead Sciences - after the United States secured nearly all of its supply of the drug over the next three months. Speaking at a news conference, the director of the Korea Centers for Disease Control and Prevention said South Korea plans to begin talks to purchase more supplies in August - making it the first country to disclose a timeline for talks with Gilead. Remdesivir is expected to be in high demand as one of the few treatments shown to alter the course of COVID-19. But the U.S. has already secured more than 500,000 treatment courses of the drug - which represents 100% of Gilead's projected production for July and 90% in August and September. The intravenously administered medicine has won emergency-use authorization in several countries and full approval in Japan after a clinical trial showed it helped shorten hospital stays. Gilead said this week it has priced remdesivir at $390 per vial in developed countries and based on current treatment patterns, a course of remdesivir equates to $2,340 per patient. The price has been a topic of intense debate since U.S. regulators approved its emergency use in some COVID-19 patients in May. Experts have said Gilead would need to avoid appearing to take advantage of a health crisis for profits. Last week, the European Union's healthcare regulator last week recommended conditional approval of the drug when used in the critically ill. The formal go-ahead by the European Commission is expected to follow soon. Gilead has linked up with generic drugmakers based in India and Pakistan, including Cipla Ltd and Hetero Labs Ltd, to make and supply remdesivir in 127 developing countries.
(Fri) Germany missed chances to catch Wirecard
¿ÍÀ̾îÄ«µå ºÎÁ¤, Àû¹ß±âȸ ³õÄ£ µ¶ÀÏ
Germany missed chances to spot the brewing trouble at Wirecard. That¡¯s according to a Reuters source with knowledge of behind-the-scenes talks. National regulators reportedly twice looked into tightening supervision of the payments firm. But ultimately took no action. That despite years of allegations of fraud by some investors and journalists. The firm then declared insolvency last week, after admitting that 2.1 billion dollars of cash on its books probably didn¡¯t exist. CEO Markus Braun has since been arrested and then released on bail. The source says German financial regulator BaFin first considered putting Wirecard on a supervision list in 2017. There were more talks, this time involving the ECB, in late 2019. But they dragged on into 2020, and were then overtaken by events. The lack of urgency is likely to intensify criticism of BaFin. It¡¯s already under fire for investigating the investors and reporters who questioned Wirecard. One whistleblower faced a criminal inquiry after alleging fraud at the firm. Last week the European Commission asked its markets watchdog to investigate whether BaFin failed in its duties. That could lead to a rare and humiliating rebuke for a national regulator.